Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjan C Lankester

Showing results (121-130 of 160) with videos related to

Pageof 16
Sort By:
British Journal of Haematology|October 5, 2023
Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working PartiesAnnamária Cseh, Jacques-Emmanuel Galimard, Josu de la Fuente, et al.
Molecular Immunology|July 29, 2008
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathwaysDirk H J Verhoeven, Alfons S K de Hooge, Esther C K Mooiman, et al.
Bone Marrow Transplantation|May 15, 2020
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Blood Advances|January 16, 2026
Acquired non-permissive BM microenvironment impairs HSCs proliferation and maintenance and B-cell development post-HSCTMelanie de Gier, Jakov Korzhenevich, Franziska Schmidt, et al.
Bone Marrow Transplantation|September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategyDanielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
Bone Marrow Transplantation|May 4, 2021
Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamideLisa V E Oostenbrink, Emma S Pool, Cornelia M Jol-van der Zijde, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2021
Hematopoietic stem cell transplantation in a patient with proteasome-associated autoinflammatory syndrome (PRAAS)Dorit Verhoeven, Dieneke Schonenberg-Meinema, Frédéric Ebstein, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor BiologyDavid M Thomas, Miriam Wilhelm, Anne-Marie Cleton-Jansen, et al.
Hematology/Oncology and Stem Cell Therapy|March 24, 2020
Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16-17 may 2019, Regensburg, Germany: What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?Lisa V E Oostenbrink, Cornelia M Jol-van der Zijde, Anja M Jansen-Hoogendijk, et al.
Bone Marrow Transplantation|March 12, 2020
The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in EuropeEliane Gluckman, Josu de la Fuente, Barbara Cappelli, et al.
Pageof 16

Showing results (121-130 of 160) with videos related to

Sort By:
Pageof 16
British Journal of Haematology|October 5, 2023
Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working PartiesAnnamária Cseh, Jacques-Emmanuel Galimard, Josu de la Fuente, et al.
Molecular Immunology|July 29, 2008
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathwaysDirk H J Verhoeven, Alfons S K de Hooge, Esther C K Mooiman, et al.
Bone Marrow Transplantation|May 15, 2020
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapyPer Ljungman, Malgorzata Mikulska, Rafael de la Camara, et al.
Blood Advances|January 16, 2026
Acquired non-permissive BM microenvironment impairs HSCs proliferation and maintenance and B-cell development post-HSCTMelanie de Gier, Jakov Korzhenevich, Franziska Schmidt, et al.
Bone Marrow Transplantation|September 22, 2021
A prospective pilot study of a novel alemtuzumab target concentration intervention strategyDanielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, et al.
Bone Marrow Transplantation|May 4, 2021
Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamideLisa V E Oostenbrink, Emma S Pool, Cornelia M Jol-van der Zijde, et al.
The Journal of Allergy and Clinical Immunology|August 20, 2021
Hematopoietic stem cell transplantation in a patient with proteasome-associated autoinflammatory syndrome (PRAAS)Dorit Verhoeven, Dieneke Schonenberg-Meinema, Frédéric Ebstein, et al.
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor BiologyDavid M Thomas, Miriam Wilhelm, Anne-Marie Cleton-Jansen, et al.
Hematology/Oncology and Stem Cell Therapy|March 24, 2020
Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16-17 may 2019, Regensburg, Germany: What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?Lisa V E Oostenbrink, Cornelia M Jol-van der Zijde, Anja M Jansen-Hoogendijk, et al.
Bone Marrow Transplantation|March 12, 2020
The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in EuropeEliane Gluckman, Josu de la Fuente, Barbara Cappelli, et al.
Pageof 16